Medical Image Segmentation on ACDC (100 patients total test)
92.9Dice ScorePCL
Evaluation Results
| Method | Links | |
|---|---|---|
| PCLM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.9 | |
| RandomM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.8 | |
| PIRLM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.7 | |
| SimCLRM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.7 | |
| GCLM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.7 | |
| RotationM (Number of patients)=80, Validation=5-fold cross-validation2021.06 | 92.5 | |
| PCLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 91.9 | |
| SimCLRM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 91.3 | |
| GCLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 91.3 | |
| PIRLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 91.2 | |
| RotationM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 91 | |
| RandomM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 90.9 | |
| PCLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 90.9 | |
| PCLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 90.4 | |
| GCLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 90.2 | |
| RotationM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 89.8 | |
| PIRLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 89.6 | |
| RandomM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 89.4 | |
| SimCLRM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 89.4 | |
| GCLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 89.1 | |
| RotationM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 88.6 | |
| PCLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 88.5 | |
| PIRLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 88 | |
| RandomM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 87.6 | |
| GCLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 87.2 | |
| SimCLRM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 86.9 | |
| RotationM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 86.8 | |
| PIRLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 86.5 | |
| PCLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 85 | |
| RandomM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 84 | |
| SimCLRM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 82.4 | |
| ProposedN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 82.4 | |
| PIRLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 82.3 | |
| RotationM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 80.9 | |
| GCLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 80.3 | |
| FedRotationN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 78.3 | |
| RandomM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 78.2 | |
| FedSwAVN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 78.2 | |
| Local CLN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 77 | |
| Random initN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 76.6 | |
| FedCAN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 76.6 | |
| FedSimCLRN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 76.5 | |
| ProposedN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 74.5 | |
| SimCLRM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 72.5 | |
| PCLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 67.1 | |
| FedRotationN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 66 | |
| FedSwAVN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 65.9 | |
| Local CLN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 63.7 | |
| GCLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 63.6 | |
| ProposedN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 63.1 | |
| FedSimCLRN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 61.9 | |
| Random initN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 61.8 | |
| FedCAN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 61 | |
| RandomM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 58.8 | |
| RotationM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 57.2 | |
| FedRotationN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 50.8 | |
| ProposedN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 50.6 | |
| PIRLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 49.2 | |
| FedSwAVN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 48 | |
| Local CLN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 45.6 | |
| FedSimCLRN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 43.5 | |
| FedCAN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 41.7 | |
| Random initN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 41.4 | |
| FedRotationN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 35.7 | |
| SimCLRM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 35.2 | |
| FedSwAVN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 32.3 | |
| Local CLN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 32 | |
| FedSimCLRN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 28.8 | |
| Random initN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 28 | |
| FedCAN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.04 | 28 |